Here are four key notes, according to the report:
1. The new device uses an external prosthetic limb, which attaches to a fixture implanted in the patient’s thigh bone.
2. According to an FDA release, there was a need for OPRA because not every patient with an above-the-knee amputation is a candidate for a prosthetic limb that connects to a custom socket.
3. Two surgical procedures are necessary to install the OPRA device.
4. The FDA approved the new prosthesis through its humanitarian device exemption pathway, according to the report.
More articles on devices:
Lucideon adds impingement testing: 5 things to know
25 spine devices receive FDA 510(k) clearance in June
St. Jude Medical receives FDA approval for wireless spinal cord stimulation: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
